Anneleen Beckers
Ghent University(BE)Cancer Research Institute Ghent(BE)
Publications by Year
Research Areas
Neuroblastoma Research and Treatments, Protein Degradation and Inhibitors, Ubiquitin and proteasome pathways, CAR-T cell therapy research, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → The need for transparency and good practices in the qPCR literature(2013)291 cited
- → Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition(2015)178 cited
- → Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma(2015)150 cited
- → A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies(2014)146 cited
- → BET bromodomain protein inhibition is a therapeutic option for medulloblastoma(2013)142 cited
- → Plasma miRNAs as biomarkers for endometriosis(2019)117 cited
- → MiR‐137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A(2013)116 cited
- → miRBase Tracker: keeping track of microRNA annotation changes(2014)88 cited
- → Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment(2015)84 cited
- → miR‐542‐3p exerts tumor suppressive functions in neuroblastoma by downregulating S urvivin(2014)83 cited